Identification of a Novel Immune-Related CpG Methylation Signature to Predict Prognosis in Stage II/III Colorectal Cancer

With the increasing incidence of colorectal cancer (CRC) and continued difficulty in treating it using immunotherapy, there is an urgent need to identify an effective immune-related biomarker associated with the survival and prognosis of patients with this disease. DNA methylation plays an essential...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Feng Chen, Lijuan Pei, Siyao Liu, Yan Lin, Xinyin Han, Erhong Meng, Xintong Wang, Shuai Hong, Dongliang Wang, Feide Liu, Yang Fei, Guangda Wang
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Frontiers Media S.A. 2021-06-01
coleção:	Frontiers in Genetics
Assuntos:	colorectal cancer CpG methylated sites biomarker prognosis immunotherapy
Acesso em linha:	https://www.frontiersin.org/articles/10.3389/fgene.2021.684349/full
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!